Nalaganje...
Trihexyphenidyl rescues the deficit in dopamine neurotransmission in a mouse model of DYT1 dystonia
Trihexyphenidyl, a nonselective muscarinic receptor antagonist, is the small molecule drug of choice for the treatment of DYT1 dystonia, but it is poorly tolerated due to significant side effects. A better understanding of the mechanism of action of trihexyphenidyl is needed for the development of i...
Shranjeno v:
| izdano v: | Neurobiol Dis |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6863078/ https://ncbi.nlm.nih.gov/pubmed/30707939 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nbd.2019.01.012 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|